 CAMBRIDGE, Mass., Jan. 05, 2022 GLOBE NEWSWIRE -- Generation Bio Co. Nasdaq: GBIO, a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced today that the company will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 12, 2022. 